Lucentis Biosimilars

Share this:

Case Study - Lucentis® Biosimilars

RAS LSS carried out a research to help one of its client, understand the overall competitive context of its Lucentis® biosimilars. The key questions answered were:
- Evolution of innovator competitive landscape in wet AMD
- Innovator competitors developing anti-VEGF candidates for wet AMD
- Biosimilar companies developing biosimilar of Lucentis®
- Comparative overviews
- Clinical evidence and ongoing development
- AMD market dynamics

Click here to download

Leave a Reply

Your email address will not be published. Required fields are marked *

*